Pro Medicus co-founders share sale announcement

Pro Medicus (ASX:PME) announced on December 4, 2024, that co-founders Dr. Sam Hupert and Mr. Anthony Hall sold 1 million shares each during the current trading window. The shares were sold to high-quality institutional investors at the closing market price of $256.73 on December 3, 2024. Despite the sale, both co-founders remain the largest shareholders, holding over 24 million shares each.

Overview and future outlook for Pro Medicus

Pro Medicus Limited's announcement highlights a strategic share sale by its co-founders to institutional investors. The sale, representing less than 4% of their individual holdings, aims to enhance the company's free float and attract new investors. Despite the sale, Dr. Sam Hupert and Mr. Anthony Hall continue to hold a significant stake, retaining over 24 million shares each and collectively owning 46% of the company. The co-founders have no immediate plans to sell further shares, emphasizing their long-term commitment. Pro Medicus, established in 1983, is a leader in healthcare informatics, offering advanced medical imaging solutions globally. The company remains focused on innovative product offerings and expanding its market reach.

Executive commentary on share sale

The decision to sell a portion of our shares was in response to strong interest from high-quality institutional investors. It is part of our strategy to gradually increase the free float of the company and provide more investment opportunities to prospective shareholders. We remain committed to the company and have no plans to sell additional shares in the foreseeable future.